![](/img/cover-not-exists.png)
PD-012Analysis of patients ≥75 years in the open-label phase 3b CONSIGN trial of regorafenib in previously treated metastatic colorectal cancer (mCRC)
Van Cutsem, E., Ciardiello, F., Ychou, M., Seitz, J.-F., Hofheinz, R., Arriaga, Y., Garcia-Carbonero, R., Grothey, A., Miriyala, A., Kalmus, J., Kappeler, C., Falcone, A., Zaniboni, A.Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw200.12
Date:
June, 2016
File:
PDF, 159 KB
2016